Share on StockTwits

Acceleron Pharma (NASDAQ:XLRN) CEO John L. Knopf unloaded 15,000 shares of Acceleron Pharma stock in a transaction that occurred on Monday, May 19th. The shares were sold at an average price of $31.52, for a total transaction of $472,800.00. Following the sale, the chief executive officer now directly owns 206,500 shares in the company, valued at approximately $6,508,880. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Shares of Acceleron Pharma (NASDAQ:XLRN) traded down 7.34% on Wednesday, hitting $29.43. 373,669 shares of the company’s stock traded hands. Acceleron Pharma has a 1-year low of $16.78 and a 1-year high of $57.89. The stock has a 50-day moving average of $34.26 and a 200-day moving average of $36.38. The company’s market cap is $892.3 million.

Acceleron Pharma (NASDAQ:XLRN) last announced its earnings results on Thursday, May 15th. The company reported ($0.30) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.44) by $0.14. The company had revenue of $3.31 million for the quarter, compared to the consensus estimate of $2.85 million. On average, analysts predict that Acceleron Pharma will post $-1.24 earnings per share for the current fiscal year.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.